Announcement: IPIC to acquire Nova Chemical-NCX for $6 per share— 02/23/09
Thoughts: Acquisition pricing has never been trickier, such as the price parameters on the Nova deal announced yesterday at 348% premium to market but that represents only 2.6X EBITDA (trailing) and on 0.28X sales. The market values are very depressed in anticipation of an unprecedented business slowdown.
About Me
- Mo Hossain (@ Ennovance Capital)
- Mr. Hossain is a private equity investor, founded Ennovance Capital to buy and build niche chemical and healthcare related companies. (Please visit: www.ennovance.com)
1 comment:
Above three companies look interesting, but I am more concerned about Ashland chemical(ASH. Would Ashland not breach its debt covenants in economy continue to deteriorate?
Post a Comment